CYP19A1 and breast cancer: Adipose-derived stromal cells isolated from breast tissue from patients with obesity led to reduced sensitivity to the aromatase inhibitor, anastrozole, when co-cultured with MCF-7 cells in a 3D organotypic breast cancer model compared to adipose-derived stromal cells isolated from women with a healthy range BMI [47].